Clinicopathologic characteristics of cutaneous chronic graft-versus-host diseases: A retrospective study in Korean patients

International Journal of Dermatology

Volumn 49, Issue 12, 2010, Pages 1386-1392

  Kim, Sun Ji ^a   Choi, Jung Min ^b   Kim, Jung Eun ^a   Cho, Baik Kee ^a   Kim, Dong Wook ^c   Park, Hyun Jeong ^a  

^a The Catholic University of Korea   (South Korea)

^b HB Dermatology Clinic   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CALCIPOTRIOL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; EMOLLIENT AGENT; FLUDARABINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS; THALIDOMIDE; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALOPECIA; APLASTIC ANEMIA; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CUTANEOUS CHRONIC GRAFT VERSUS HOST DISEASE; DISEASE SEVERITY; ECZEMA; ERYTHEMA; ERYTHEMA MULTIFORME; EXFOLIATIVE DERMATITIS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; ICHTHYOSIS; KERATOSIS; LICHENOID; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PHOTOTHERAPY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SCLERODERMA; SKIN MANIFESTATION; WHOLE BODY RADIATION; XEROSIS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SKIN DISEASES; YOUNG ADULT;

EID: 78649402400     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04552.x     Document Type: Article

References (25)

1. Appelbaum FR. The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer. CA Cancer J Clin 1996; 46: 142-164.
2. Copelan EA. Hematopoietic stem-cell transplantation. N Eng J Med 2006; 354: 1813-1826.
3. Barkholt L, Bregni M, Remberger M, et al. Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe. Ann Oncol 2006; 17: 1134-1140.
4. Lee SJ, Klein JP, Barrett AJ, et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 2002; 100: 406-414.
5. Higman MA, Vogelsang GB. Chronic graft versus host disease. Br J Haematol 2004; 125: 435-454.
6. Schaffer JV. The changing face of graft-versus-host disease. Semin Cutan Med Surg 2006; 25: 190-200.
7. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956.
8. Sullivan KM, Shulman HM, Storb R, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267-276.
9. Johnson ML, Farmer ER. Graft-versus-host reactions in dermatology. J Am Acad Dermatol 1998; 38: 369-392.
10. Häusermann P, Walter RB, Halter J, et al. Cutaneous graft-versus-host disease: a guide for the dermatologist. Dermatology 2008; 216: 287-304.
11. Aractingi S, Chosidow O. Cutaneous graft-versus-host disease. Arch Dermatol 1998; 134: 602-612.
12. Andrews ML, Robertson I, Weedon D. Cutaneous manifestations of chronic graft-versus-host disease. Australas J Dermatol 1997; 38: 53-62.
13. Hymes SR, Turner ML, Champlin RE, et al. Cutaneous manifestations of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2006; 12: 1101-1113.
14. Creamer D, Martyn-Simmons CL, Osborne G, et al. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy. Arch Dermatol 2007; 143: 1157-1162.
15. Sanli H, Ekmekçi P, Arat M, et al. Clinical manifestations of cutaneous graft-versus-host disease after allogeneic haematopoietic cell transplantation: long-term follow-up results in a single Turkish centre. Acta Derm Venerel 2004; 84: 296-301.
16. Vowels M, Chan LL, Giri N, et al. Factors affecting hair regrowth after bone marrow transplantation. Bone Marrow Transplant 1993; 12: 347-350.
17. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
18. Shulman HM, Sale GE, Lerner KG, et al. Chronic cutaneous graft-versus-host disease in man. Am J Pathol 1978; 91: 545-570.
19. Sanli H, Arat M, Oskay T, et al. Evaluation of nail involvement in patients with chronic cutaneous graft versus host disease: a single-center study from Turkey. Int J Dermatol 2004; 43: 176-180.
20. Yang JS, Park HJ, Lee JY, et al. Chronic cutaneous graft versus host disease: clinicopathologic study. Korean J Dermatol 2003; 41: 187-196.
21. Arora M, Nagaraj S, Witte J, et al. New classification of chronic GVHD: added clarity from the consensus diagnoses. Bone Marrow Transplant 2009; 43: 149-153.
22. Goerner M, Gooley T, Flowers ME, et al. Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. Biol Blood Marrow Transplant 2002; 8: 47-56.
23. Sullivan KM, Witherspoon RP, Storb R, et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood 1988; 72: 555-561.
24. Socié G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Eng J Med 1999; 341: 14-21.
25. Bhatia S, Francisco L, Carter A, et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 2007; 110: 3784-3792.